Winship Cancer Institute, Emory University — Atlanta, Georgia

Public research footprint of Winship Cancer Institute, Emory University, compiled from the ClinicalTrials.gov public registry.

182

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Resectable Non-Small-Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Resectable Pancreatic Ductal Adenocarcinoma (PDAC)

Recently updated registry entries

NCT07284758 — A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With… (Recruiting)
NCT07217171 — A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in… (Recruiting)
NCT07213804 — A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Winship Cancer Institute, Emory University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.